Rekor Systems Announces Strategic On-Shoring of Overseas Engineering Operations to Advance Cost Discipline and Operational Efficiency
Globenewswire· 2026-02-24 12:30
Action Bolsters Support for Customer Base While Cutting Annual Operating Expenses by Approximately $7.5 MillionCOLUMBIA, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rekor Systems, Inc. (NASDAQ: REKR) ("Rekor or the "Company"), a global leader in roadway intelligence, today announced a strategic consolidation of its worldwide engineering operations aimed at increasing operational efficiency and aligning the Company's cost structure with current revenue levels. As part of this initiative, Rekor will move engineeri ...
Stardust Power Joins Cornerstone Consortium to Support U.S. Critical Minerals and Industrial Base Resilience
Globenewswire· 2026-02-24 12:30
GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium carbonate, today announced that it has joined the Cornerstone Consortium, a U.S. Department of Defense aligned collaborative framework focused on strengthening the domestic industrial base and securing critical supply chains. The Cornerstone Consortium brings together a broad range of domestically held organizations, including the U.S. Dep ...
Apogee Therapeutics to Participate in Upcoming March Conferences
Globenewswire· 2026-02-24 12:30
Company Overview - Apogee Therapeutics, Inc. is a clinical-stage biotechnology company focused on advancing novel biologics for inflammatory and immune (I&I) markets, including treatments for Atopic Dermatitis (AD), asthma, Eosinophilic Esophagitis (EoE), and Chronic Obstructive Pulmonary Disease (COPD) [3] - The company's lead program, Zumilokibart (APG777), is being developed primarily for AD, which is identified as the largest and least penetrated market within I&I [3] - Apogee aims to achieve best-in-class efficacy and dosing through its antibody programs, which target established mechanisms of action and utilize advanced antibody engineering [3] Upcoming Events - Management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 3, 2026, at 9:10 a.m. E.T. [1] - The company will also attend the UBS Biotech Summit Miami on March 9, 2026, and the Jefferies Biotech on the Beach Summit on March 10, 2026 [1] Investor Relations - For investor inquiries, Noel Kurdi serves as the VP of Investor Relations at Apogee Therapeutics [4] - Media inquiries can be directed to Dan Budwick at 1AB [4]
TopBuild to Acquire Johnson Roofing
Globenewswire· 2026-02-24 12:30
Core Viewpoint - TopBuild Corp. has announced the acquisition of Johnson Roofing, enhancing its commercial roofing services platform and expanding its market presence in Texas [1][2]. Company Overview - TopBuild Corp. is a leading installer of insulation and commercial roofing, as well as a specialty distributor of insulation and related building products in the U.S. and Canada [3]. - The company operates over 200 branches for installation services and more than 250 branches for specialty distribution across the U.S. and Canada [3]. Acquisition Details - Johnson Roofing, founded in 1941, generates approximately $29 million in annual revenue and is one of the largest commercial roofing installation service providers in Texas [1]. - The acquisition is expected to allow TopBuild to capitalize on a fragmented commercial roofing market and better serve general contractor customers [2]. Leadership Statements - Robert Buck, President and CEO of TopBuild, expressed enthusiasm about integrating Johnson Roofing into the company to enhance shareholder value [2]. - Sherri Johnson, leader of Johnson Roofing, highlighted the alignment of company cultures focused on safety and excellence [2].
Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples
Globenewswire· 2026-02-24 12:30
Mainz Biomed to Present Industry Leading Results: 100% Sensitivity and 95% SpecificityBERKELEY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, is excited to announce its participation in the renowned Digestive Disease Week (DDW) 2026 in Chicago, Illinois. At the conference the Company will present its poster titled “BLOOD-BASED MRNA SIGNATURE FOR DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA A ...
Rio Silver Inc. Invites Investors to Meet Management at PDAC 2026, the World’s Premier Mining Convention
Globenewswire· 2026-02-24 12:30
Silver-Dominant Maria Norte Project in Peru to Be Featured at PDAC 2026 Mining Convention as Company Advances Development StrategyVANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX-V: RYO | OTC: RYOOF) is pleased to invite current and prospective investors to meet with management at the Prospectors & Developers Association of Canada (PDAC) Convention 2026, the foremost global mining and mineral exploration conference. The PDAC Convention 2026 ...
ZenaTech Wins the Morrissey Goodale 2026 Most Prolific and Proficient Acquirer Award for Growing its Drone as a Service Network
Globenewswire· 2026-02-24 12:30
VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces it has won the 2026 Most Prolific and Proficient Acquirer Award from Morrissey Goodale – a renowned management consulting and advisory firm exclusively serving the architecture, engineering, and environmental (AE ...
Glass House Brands Board of Directors Establishes Product Expansion Committee to Support New Product and Business Development
Globenewswire· 2026-02-24 12:30
Core Viewpoint - Glass House Brands Inc. is establishing a Special Committee to oversee new product development and business expansion beyond its California cannabis operations, aiming to explore partnership opportunities with traditional industry players [1][5]. Group 1: Special Committee Formation - The Special Committee includes key Board members such as Kyle Kazan (Co-Founder, Chairman, and CEO), Graham Farrar (Co-Founder and President), Joceyln Rosenwald (Co-Founder), and independent directors Jay Nichols and Alison Payne [2]. - Jay Nichols has been appointed as Chairman of the Special Committee, bringing over 40 years of experience in corporate strategy and operations [3]. - Alison Payne is recognized for her expertise in branding and marketing, currently serving as Chief Marketing Officer of Heineken, USA [4]. Group 2: Strategic Goals and Market Opportunities - The committee's mandate is to evaluate new business prospects and ensure the company is prepared to capitalize on upcoming opportunities related to cannabis reform [5]. - The company anticipates that rescheduling cannabis to Schedule III could open up international medical market opportunities, with a potential annual market size of $30 billion for a reimbursable CBD program [5]. - Glass House is accelerating its cultivation and production capacity through the development of Greenhouses 2 and 4, aiming to meet rising demand in both domestic and international markets [5]. Group 3: Industry Positioning - Glass House is positioned to leverage its experience in cannabis cultivation to supply the Medicare reimbursable CBD market and to partner with traditional industry companies for product development [5][6]. - The company aims to enhance its core competency in low-cost, high-quality cannabinoid production to thrive in the evolving market landscape [5].
Giant Containers Retained to Design, Deliver New Modular Structures for World-Leading EV Company
Globenewswire· 2026-02-24 12:30
Project supports client’s continued expansion with multiple custom steel modular systems across several U.S. sitesCONROE, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- via IBN – Giant Containers, a subsidiary of Olenox Industries (Nasdaq: OLOX), today announced it has been retained to design and deliver new modular solutions for a leading electric vehicle (EV) company across multiple U.S. locations. The multi-site engagement will focus on the design, manufacture and deployment of scalable, modular buildings that ...
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Globenewswire· 2026-02-24 12:30
Fourth quarter revenue of $198 million, a year-over-year increase of 18% as reported, 14% organic with continued momentum in orders in the quarterFull year 2025 revenue of $738 million, a year-over-year increase of 16% for both reported and organic non-COVIDFull year 2026 revenue guidance of $810 million - $840 million, 10% to 14% reported revenue growth, 9% to 13% organic and adjusted operating margin expansion of 150 bps at the midpoint WALTHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Repligen Corporatio ...